8-K filing — Atkore Inc. (ATKR)
Filed: 2026-10-08 AccNo: 0001666138-26-000039 Size: 173 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
This Walmart Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Analysts changed ratings for ATKR, CI, NKE, WMT, and OLN. See how they view these stocks and consider buying WMT.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Cigna Group (CI)
Filed: 2026-10-09 AccNo: 0001140361-26-039271 Size: 137 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders
Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance
CMS Releases 2027 Medicare Advantage And Part D Star Ratings, With 37% Of MA-PD Contracts Earning Four Or More Stars And 71% Of Enrollees In High-Rated Plans
Robert Kennedy Jr. Pushes New Healthcare Pricing Rules as HHS Says Patients Deserve Clearer Costs: ‘Americans Should Know…’
HHS and CMS finalize new healthcare price transparency rules, requiring quarterly pricing reports and phone-based cost estimates.
Just 26% of Wall Street Analysts Rate Nike a Buy. Is It Time to Be Greedy While Others are Fearful?
Nike's stock has plummeted over 50% as CEO Elliott Hill's turnaround strategy has failed to reverse declining sales, particularly in China where revenue dropped 26% year-over-year. With only 26% of analysts rating it a buy and competitors like On Holding and Deckers Outdoor gaining market share with stronger margins, the article suggests waiting for the new Pace cost-cutting plan to show results before investing, rather than buying into the current pessimism.